Grape, tulsi basil and ume flavors shine
For telehealth-only patients, the extra $60 to $80 per month over the lowest-cost competitors buys you a more clinician-involved model, but you could get similar clinical density from Mochi or Lavender Sky at comparable or lower price points
Vincere has received support from top-tier investors, including Draper Associates, LongGame, Castor Capital, Portal Innovations, Quadrascope, Healthspan Capital, KreaMedica, Freemind Investment, Beresford Ventures, Daewoong Pharma, and HanAll Biopharma, among others
Delaying type 2 diabetes: A2017 studytested L-arginine supplementation in middle aged adults with metabolic syndrome and impaired glucose tolerance
The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study at 30 years: overview